Home › Funds › Nicholas Investment Partners, LP › ROIV

Nicholas Investment Partners, LP position in ROIV

ROIVANT SCIENCES LTD · Health Care

Nicholas Investment Partners, LP reported holding 462,464 shares of ROIV (ROIVANT SCIENCES LTD) in its Q3 2026 13F filing — a position valued at US$16.9M, representing 1.27% of its reported portfolio and ranking #17 among its reported holdings. Nicholas Investment Partners, LP has disclosed ROIV holdings in 7 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)462.46K sh
Reported value held$16.91M
Portfolio Weight1.27%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Nicholas Investment Partners, LP's ROIV position evolved

Nicholas Investment Partners, LP first disclosed a stake in ROIV in Q3 2023 at 2,998,135 shares (US$35.0M). Across 7 filings, Nicholas Investment Partners, LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 462,464 shares valued at US$16.9M — an increase of 43,184 shares quarter over quarter.. Notable position changes include a 95% trim in Q4 2023 (shares fell 6% over the following quarter), a 51% increase in Q2 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.00M $35.02M New
Q4 2023 158.01K $1.77M Reduce
Q3 2025 245.62K $3.72M New
Q4 2025 279.86K $6.07M Add
Q1 2026 278.43K $7.71M Reduce
Q2 2026 419.28K $14.84M Add
Q3 2026 462.46K $16.91M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ROIV and 13F data

ROIV (ROIVANT SCIENCES LTD) is a Health Care company. 57 other funds we track also report a position in ROIV — the largest reported positions include QVT Financial LP (US$839.6M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$795.2M), Farallon Capital Management (US$506.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ROIV

All ROIV fund holders →

FAQ

How long has Nicholas Investment Partners, LP held ROIV?

Nicholas Investment Partners, LP has disclosed ROIV holdings in 7 of the last 13 reported quarters, going back to Q3 2023.

What is Nicholas Investment Partners, LP's current position in ROIV?

As of Q3 2026, Nicholas Investment Partners, LP holds 462.46K shares of ROIV (ROIVANT SCIENCES LTD), valued at $16.91M, representing 1.27% of its reported portfolio and ranking #17.

Has Nicholas Investment Partners, LP been buying or selling ROIV?

In the latest 13F filing (Q3 2026), Nicholas Investment Partners, LP increased its position in ROIV.

Which other funds hold ROIV?

Other major institutional holders of ROIV include QVT Financial LP, FARALLON CAPITAL MANAGEMENT, L.L.C., Farallon Capital Management, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.